Search clinical trials for: 177Lu-3BP-227 (also called 177Lu-IPN01087)
Total 9 results
-
IpsenTerminatedGastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic TumoursUnited States, France, Belgium, Switzerland, Netherlands
-
Peter MacCallum Cancer Centre, AustraliaUnited States Department of Defense; Advanced Accelerator Applications; Australian... and other collaboratorsActive, not recruitingMetastatic Hormone Naive Prostate CancerAustralia
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Not yet recruitingProstate Cancer | Advanced Cancer
-
Istituto Scientifico Romagnolo per lo Studio e...Istituto Europeo di Oncologia IEO MILANOActive, not recruitingNeuroendocrine Tumors | Gastro Entero Pancreatic Neuroendocrine TumorsItaly
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...Active, not recruitingNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic DiseaseAustralia
-
Jules Bordet InstituteWithdrawnGastro-intestinal Neuroendocrine TumorsBelgium
-
IpsenTerminatedNeuroendocrine TumorsUnited States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
-
National Cancer Institute (NCI)RecruitingMetastatic Pancreatic Neuroendocrine Tumor | Pancreatic Neoplasm | Stage III Pancreatic Neuroendocrine Tumor AJCC v8 | Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 | Unresectable Pancreatic Neuroendocrine TumorUnited States, Canada